Brief: Abivax Announces First Patient Enrolled In Enhance-Cd, The Phase 2B Trial Of Obefazimod In Crohn’S Disease
03/10/2024 21:36
Abivax SA ABVX.PA :
* ABIVAX ANNOUNCES FIRST PATIENT ENROLLED IN ENHANCE-CD, THE
PHASE
2B TRIAL OF OBEFAZIMOD IN CROHN’S DISEASE
Source text for Eikon: ID:nGNX2mHrsD
Further company coverage: ABVX.PA
Recent news on Abivax SA
See all newsAbivax shares fall after rival drug data, trader says
France's Abivax H1 net loss widens on higher expenses driven by clinical programs
U.S. RESEARCH ROUNDUP-Caseys General Stores, Targa Resources, United Rentals
GS starts Abivax at 'buy,' sees multibillion sales potential for lead drug candidate
Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data